These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD. Okura Y, Yamada M, Kuribayashi F, Kobayashi I, Ariga T. J Clin Immunol; 2015 Feb 05; 35(2):158-67. PubMed ID: 25666294 [Abstract] [Full Text] [Related]
28. Chronic Granulomatous Disease and Myelodysplastic Syndrome in a Patient with a Novel Mutation in CYBB. Reis BCS, Cunha DP, Bueno APS, Carvalho FAA, Dutra J, Mello FV, Ribeiro MCM, Milito CB, da Costa ES, Vasconcelos Z. Genes (Basel); 2021 Sep 23; 12(10):. PubMed ID: 34680870 [Abstract] [Full Text] [Related]
29. Lentiviral gene therapy for X-linked chronic granulomatous disease recapitulates endogenous CYBB regulation and expression. Wong RL, Sackey S, Brown D, Senadheera S, Masiuk K, Quintos JP, Colindres N, Riggan L, Morgan RA, Malech HL, Hollis RP, Kohn DB. Blood; 2023 Mar 02; 141(9):1007-1022. PubMed ID: 36332160 [Abstract] [Full Text] [Related]
30. Regulation of NADPH oxidase activity in phagocytes: relationship between FAD/NADPH binding and oxidase complex assembly. Debeurme F, Picciocchi A, Dagher MC, Grunwald D, Beaumel S, Fieschi F, Stasia MJ. J Biol Chem; 2010 Oct 22; 285(43):33197-33208. PubMed ID: 20724480 [Abstract] [Full Text] [Related]
31. Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the cytosolic gp91phox C-terminal tail. Stasia MJ, Lardy B, Maturana A, Rousseau P, Martel C, Bordigoni P, Demaurex N, Morel F. Biochim Biophys Acta; 2002 Apr 24; 1586(3):316-30. PubMed ID: 11997083 [Abstract] [Full Text] [Related]
32. Molecular characterization of a novel splice site mutation within the CYBB gene leading to X-linked chronic granulomatous disease. Barese CN, Copelli SB, De Matteo E, Zandomeni R, Salgueiro F, Di Giovanni D, Heyworth P, Rivas EM. Pediatr Blood Cancer; 2005 Apr 24; 44(4):420-2. PubMed ID: 15468310 [Abstract] [Full Text] [Related]
33. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece. Raptaki M, Varela I, Spanou K, Tzanoudaki M, Tantou S, Liatsis M, Constantinidou N, Bakoula C, Roos D, Kanariou M. J Clin Immunol; 2013 Nov 24; 33(8):1302-9. PubMed ID: 24081483 [Abstract] [Full Text] [Related]
34. Intersecting Stories of the Phagocyte NADPH Oxidase and Chronic Granulomatous Disease. Nauseef WM, Clark RA. Methods Mol Biol; 2019 Nov 24; 1982():3-16. PubMed ID: 31172463 [Abstract] [Full Text] [Related]
36. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties. Wolach B, Broides A, Zeeli T, Gavrieli R, de Boer M, van Leeuwen K, Levy J, Roos D. J Clin Immunol; 2011 Aug 24; 31(4):560-6. PubMed ID: 21604087 [Abstract] [Full Text] [Related]
38. High-level reconstitution of respiratory burst activity in a human X-linked chronic granulomatous disease (X-CGD) cell line and correction of murine X-CGD bone marrow cells by retroviral-mediated gene transfer of human gp91phox. Ding C, Kume A, Björgvinsdóttir H, Hawley RG, Pech N, Dinauer MC. Blood; 1996 Sep 01; 88(5):1834-40. PubMed ID: 8781441 [Abstract] [Full Text] [Related]
39. Identification of a novel mutation in CYBB gene in a Chinese neonate with X-linked chronic granulomatous disease: A case report. Zhang J, Fan M, Chen M, Wang H, Miao N, Yu H, Zhang L, Deng Q, Yi C. Medicine (Baltimore); 2022 Mar 11; 101(10):e28875. PubMed ID: 35451380 [Abstract] [Full Text] [Related]